Clinical evaluation of XXXX and @entity5503 in @entity1729 .

@entity1 @entity5503 @entity1729 @entity35496
Eighty-two adult hospitalized @entity1 suffering from @entity1729 were treated with @entity35496 or @entity5503 in an open comparative study. The @entity1 were allocated randomly to one of the two treatments. The recommended dosage regimens (i.m. or i.v.) were used for both groups ( @entity35496 1 g b.i.d., @entity5503 1 g t.i.d.). The duration of treatment was 7 to 14 days according to the response of the disease condition. 80 @entity1 were analyzed. The tolerability of both drugs was good and comparable. The clinical and bacteriological efficacy of both drugs was equivalent. The radiological examinations showed a better improvement of the @entity1 treated with @entity35496 .
